Patents by Inventor Vincent Verlant

Vincent Verlant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic composition
    Patent number: 9561268
    Abstract: The present invention relates to immunogenic compositions comprising one or more Streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising Protein E and/or PilA from Haemophilus influenzae.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: February 7, 2017
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Francesca Ceddia, William Paul Hausdorff, Vincent Verlant, Carine Ysebaert
  • IMMUNOGENIC COMPOSITION
    Publication number: 20140193451
    Abstract: The present invention relates to immunogenic compositions comprising 26 ?g-45 ?g of pneumolysin and/or PhtD, vaccines comprising the immunogenic compositions and their use in medicine.
    Type: Application
    Filed: March 14, 2013
    Publication date: July 10, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventor: VINCENT VERLANT
  • IMMUNOGENIC COMPOSITION
    Publication number: 20140105926
    Abstract: The present invention relates to immunogenic compositions comprising one or more Streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising Protein E and/or PilA from Haemophilus influenzae.
    Type: Application
    Filed: March 14, 2013
    Publication date: April 17, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Francesca Ceddia, William Paul Hausdorff, Vincent Verlant, Carine Ysebaert
  • IMMUNOGENIC COMPOSITION
    Publication number: 20140105927
    Abstract: The present invention relates to an immunogenic composition comprising (i) at least one Streptococcus pneumoniae protein; (ii) a Streptococcus pneumoniae capsular saccharide derived from a strain of a targeted serotype of Streptococcus pneumoniae; for use in enhancing antibody-mediated opsonic activity against the targeted serotype of Streptococcus pneumoniae.
    Type: Application
    Filed: March 14, 2013
    Publication date: April 17, 2014
    Applicant: GlaxoSmithKline Biologicals S.A.
    Inventor: VINCENT VERLANT
  • VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE
    Publication number: 20140072622
    Abstract: The present invention relates to improved immunogenic compositions and vaccines, methods for making them and their use in medicine. In particular the invention relates to immunogenic compositions of unconjugated Streptococcus pneumoniae proteins selected from: pneumolysin and member(s) of the Polyhistidine Triad family (e.g. PhtD), which comprise adjuvants comprising QS21 and monophosphoryl lipid A (MPL), and are presented in the form of a liposome.
    Type: Application
    Filed: May 15, 2012
    Publication date: March 13, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Philippe Denoel, Jan Poolman, Vincent Verlant, Hugues Wallemacq